Our Location
304 North Cardinal St.
Dorchester Center, MA 02124
Product Name: Cabozanix
Generic Name: Cabozantinib
Formation: Tablet
Available Pack Size: 90’s plot and 30’s plot
Strength: 20mg and 60mg
Cabozanix-20mg-Cabozantinib is a drug that is used to treat specific cancers. It is an oral, small-molecule tyrosine kinase inhibitor that targets MET, VEGFR (vascular endothelial growth factor receptor), and RET, in addition to other RTKs. Cabozanix-20mg assists in preventing tumor growth, angiogenesis (the growth of new blood vessels to support the tumor), and metastasis (the spread of cancer to other parts of the body) by inhibiting these kinases.
For patients who have previously received other systemic therapies, the drug Cabozanix-20mg is approved for the treatment of several cancers, including advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). In some cases of medullary thyroid cancer, it may also be applied.
It’s important to remember that Cabozanix-20mg, like many cancer treatments, can have side effects and that its use should be carefully monitored by medical professionals. Fatigue, diarrhea, hand-foot syndrome (painful swelling or blisters on the palms of the hands and soles of the feet), hypertension (high blood pressure), and other side effects are examples of common adverse reactions.
Patients must discuss the potential advantages and disadvantages of Cabozanix-20mg with their oncologist or healthcare provider before beginning any medical procedure to choose the best course of action for their particular condition. (1)
Cabozanix-20mg-Cabozantinib is a multi-indication cancer treatment that is indicated for the treatment of the following:
Cabozanix-20mg-Cabozantinib is a multi-kinase inhibitor that inhibits the activity of specific proteins known as receptor tyrosine kinases (RTKs) toorder to produce its desired effects. RTKs play a role in several cellular functions, such as cell division, growth, and survival. Overactive RTKs can promote the growth and metastasis of cancer cells.
Cabozanix-20mg specifically inhibits the activity of the following RTKs:
By blocking the activity of these RTKs, Cabozanix-20mg can slow down or stop cancer cell growth and metastasis. It can also help shrink tumors and improve survival rates.
In addition to its direct effects on tumor cells, Cabozanix-20mg can also affect the tumor microenvironment. The tumor microenvironment is the tissue and cells that surround a tumor. It can play a role in tumor growth and metastasis. Cabozanix-20mg can help normalize the tumor microenvironment, making it more difficult for the tumor to grow and spread.
Cabozanix-20mg is a highly effective cancer treatment, but it can also cause serious side effects. The most common side effects include diarrhea, nausea, fatigue, hypertension, and hand-foot syndrome. Less common but more serious side effects can include liver damage, kidney damage, and bleeding. It is important for patients to closely monitor their symptoms and report any concerning side effects to their healthcare provider. Regular check-ups and blood tests may be necessary to monitor organ function while taking Cabozanix-20mg. In some cases, the benefits of the treatment may outweigh the potential risks, especially for patients with advanced or metastatic cancer. However, it is crucial for healthcare providers to carefully weigh the potential benefits against the risks before prescribing Cabozanix-20mg to a patient. (3)
Cabozanix-20mg-Cabozantinib dosage and administration depend on the cancer type and individual medical condition. Doctors determine the best dosage and schedule. For advanced renal cell carcinoma, 60 mg daily is recommended, while for hepatocellular carcinoma and DTC, 40 mg daily is recommended. Doctors may adjust dosage based on response and side effects.
Here are some general guidelines for taking Cabozanix-20mg:
Cabozanix-20mg-Cabozantinib is a drug that can have several negative side effects, such as diarrhea, nausea, vomiting, fatigue, high blood pressure, hand-foot syndrome, decreased appetite, hair loss, dry skin, mouth sores, constipation, headache, muscle pain, joint pain, difficulty sleeping, and rash. Liver damage, kidney damage, bleeding, blood clots, heart problems, lung problems, infection, seizures, and stroke are less frequent but more severe side effects. Consult your doctor for advice on how to deal with any of these side effects or how to change the dosage if you experience any of them.
The brand names of cabozantinib are:
Cometriq is used to treat medullary thyroid cancer. Cabometyx is used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and locally advanced or metastatic differentiated thyroid cancer.
The price of cabozantinib can vary depending on the brand name, dosage, and pharmacy where you purchase it. However, it is generally a very expensive medication.
According to GoodRx, the average cost of a 30-day supply of Cabometyx 40 mg tablets is $52,576.54. The price can range from $24,943.93 to $65,157.26, depending on the pharmacy.
The generic version of this medicine is Cabozanix-20mg which is much less from the brand name medicine and effective as the brand one. (4)
Cabozanix-20mg-Cabozantinib Success Rate:
As an AI language model, I don’t have access to real-time data or individual patient stories past my knowledge cutoff in September 2021. Additionally, sharing specific patient success stories would require accessing private and confidential information, which I don’t have.
However, it is not uncommon to find success stories or testimonials from patients who have undergone cabozantinib treatment for various types of cancer. Some patients may experience significant tumor shrinkage, improved quality of life, and extended survival rates due to the effectiveness of cabozantinib in treating their specific condition.
Cabozantinib’s life expectancy varies based on the cancer type and individual condition. However, it has been shown to improve survival rates in various cancers. In a clinical trial, it increased median overall survival in patients with advanced renal cell carcinoma, extended it in those with hepatocellular carcinoma who had previously received sorafenib, and extended it in patients with locally advanced or metastatic differentiated thyroid cancer who had progressed after prior VEGFR-targeted therapy.
See our other medicine Axinix-5mg, Palbonix100/125mg, Ibrutix-140mg,
Read the Blog on our site PARP inhibitors an ovarian and breast cancer treatment.
What are the side effects of Cabozantinib?
What is Cabozantinib mechanism of action?
How quickly does cabozantinib work?
Is cabozantinib chemotherapy?
How does cabozantinib work?
How effective is cabozantinib?
How long does cabozantinib work?
You must be logged in to post a review.
Reviews
There are no reviews yet.